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In order to assess mechanisms underlying inflammatory activation during extracorporeal circulation (ECC), several small animal
models of ECC have been proposed recently. The majority of them are based on home-made, nonstandardized, and hardly
reproducible oxygenators.The present study has generated fundamental information on the role of oxygenator of ECC in activating
inflammatory signaling pathways on leukocytes, leading to systemic inflammatory response, and organ dysfunction. The present
results suggest that experimental animal models of ECC used in translational research on inflammatory response should be based
on standardized, reproducible oxygenators with clinical characteristics.
1. Introduction
Extracorporeal circulation (ECC) is essential for cardiopul-
monary bypass (CPB) during conventional cardiac surgery
and extracorporeal membrane oxygenation (ECMO) during
extracorporeal life support [1].
Systemic inflammation after ECC is believed to con-
tribute to various pathophysiological outcomes, including
renal, pulmonary, and myocardial damage [2]. The under-
lying mechanism is likely to be multifactorial, involving
operative trauma, hemodilution and endothelial damage
by edema, ischemia/reperfusion of organs, and contact-
activation of blood components during ECC [2, 3]. The
latter is known to have a pivotal role even after recent
improvements in materials and techniques. Despite these
insights, the mechanisms that control systemic inflammatory
response during ECC remain poorly characterized at the
molecular level. To address this issue several experimental
animal models have been described [4–10]. The rat model of
ECC is more accessible and less expensive compared to large
animal models. Indeed it allows large availability of assay also
with transgenic, knock-out, and syngenic species. Most of the
models currently described in literature are based on home-
made oxygenators [4–10]. We have recently reported the
validation of a rat model of ECC with a miniaturized hollow
fiber oxygenator with current clinical standards produced by
one of the leading companies in the clinical field [11].
In the present study we aimed to assess the role of oxy-
genator, manufactured with industrial standards and clinical
characteristics, in the development of leukocyte activation
and systemic inflammation in a rat model of ECC.
2. Methods
After institutional animal care committee approval, 20 male
Wistar rats (400–450 g; Harlan, Udine, Italy) housed under
standard laboratory conditions were anesthetized (sodium
pentobarbital, 30mg/kg intraperitoneally) and intubated
Hindawi Publishing Corporation
Mediators of Inﬂammation
Volume 2015, Article ID 484979, 7 pages
http://dx.doi.org/10.1155/2015/484979
2 Mediators of Inflammation
through the oropharynx with a 14-gauge polyethylene tube.
They were mechanically ventilated with a rodent respirator
(HarvardApparatus Inc., Holliston,Massachusetts).The tidal
volume was 7mL/kg and the respiratory rate was 50 to
60 breaths/min with an air-oxygen mixture (inspired oxygen
fraction = 0.5). Ventilation was adjusted to keep an arterial
carbon dioxide tension of 35 to 45mmHg. Rats were secured
supine on a heating board to maintain rectal temperature
at 37∘C during the surgical procedure before the initiation
of ECC. The left femoral artery was cannulated with a hep-
arinized 24-gaugeTeflon catheter tomonitor systemic arterial
pressure and to collect arterial blood for gas analysis. Central
cannulation was performed as previously described [11, 12].
In brief, after complete sternotomy, a venous cannula (a
modified 4-hole 16-gauge Angiocath catheter) was advanced
into the right atrium using a right transsuperior vena cava
approach, allowing excellent drainage. The left common
carotid artery was cannulated using an 18-gauge catheter
advanced to the aortic arch. Another 18-gauge catheter was
inserted into the right femoral vein and advanced into
inferior vena cava.
Full heparinization (500 IU/kg) was assured after surgical
preparation and immediately before ECC initiation to reduce
overall blood loss. ECCwas set up as previously described [11,
12]. The setup consisted of a venous reservoir, a roller pump,
a hollow fiber oxygenator (Sorin, Mirandola, Italy), and a
vacuumregulatorwith an applied pressure of−30mmH
2
Oto
facilitate venous drainage, all connected by 1.6-mm internal
diameter plastic tubing. Total priming volume was 10.5mL,
gas exchange surface was 450 cm2, and heat exchange surface
was 15.8 cm2.
2.1. Study Design. Rats were randomized into two groups.
The first group received the blood returned from the ECC
circuit into the cannula positioned into the left common
carotid artery.
In the second group of animals the oxygenator was not
present in the ECC circuit and the blood was returned from
the ECC circuit into the cannula allocated into the right
femoral vein.
ECC was instituted in both groups at a flow rate of
120mL/kg/min for 60minutes. After the experiment, animals
were humanely killed by anesthetic overdose.
2.2. Measurements. To access the inflammation induced by
ECC in the two groups studied, blood samples were collected
before and after ECC.
One hundred microliters of whole blood in ethylenedi-
aminetetraacetic acid was determined by color immunofluo-
rescent flow-cytometry analysis (FACSCalibur/BDCellQuest
Pro software; Becton Dickinson, Tokyo, Japan).
Whole blood samples were incubated with Becton Dick-
inson (Franklin Lakes, NJ) lyse/fix buffer (containing phos-
phatase inhibitors) for 10 minutes at 37∘C. Leukocytes were
then isolated by centrifugation (300 g for 5 minutes) and
washed once with phosphate-buffered saline. Cells were
resuspended in 0.5mL prechilled Becton Dickinson Perm
Buffer III, vortexed, and incubated on ice for 30 minutes.
After this, cells were washed twice with phosphate-buffered
saline and resuspended in 0.5mL Becton Dickinson Stain-
Buffer (fetal bovine serum) before incubation for 30 min-
utes (at room temperature) with PE-Cy7- or PE-conjugated
antibodies that recognized Ser529 phosphorylated RelA (p65;
NF-𝜅B) or Thr180/Tyr182 phosphorylated p38 or isotype-
matched controls, with subsequent washing and analysis
by flow-cytometry (Becton Dickinson). Fluorescence of PE-
conjugated p65 and PE-Cy7-conjugated p38 MAP kinase
antibodies was quantified in granulocytes or mononuclear
cells (identified by forward and side scatter plots) using
Summit 4.3 software (Dako, Glostrup, Denmark).
The levels of TNF-𝛼 (Thermo scientific, Rockford, IL,
USA), IL-6 (Thermo scientific, Rockford, IL, USA), and neu-
trophil elastase (NE, cloud-clone, Houston, TX, USA) were
determined by Enzyme Linked Immunoadsorbent Assay
(ELISA) kits, according to the manufacturer’s instruction.
To access the inflammation in organ tissue, right lung
was harvested immediately after euthanasia. Therefore it was
fixed in 4% paraformaldehyde at 4∘C overnight. Paraffin-
embedded sections (3 𝜇m) were stained with hematoxylin
and eosin (H&E) and examined by microscope analysis by a
pathologist blinded to the experimental groups. The severity
of lung injury was scored using a 5-point scale according to
combined assessment of alveolar congestion, haemorrhage,
accumulation of neutrophils in the airspace or vessel wall, and
the thickness of alveolar wall/hyaline membrane formation
with minimal 0 for normal lung histology and maximum 5
for most injured lung [13].
2.3. Statistic. Statistical analysis was performed using SPSS
11.0 software (SPSS Inc., USA). Results are reported asmean±
standard error (SE). Comparison between groups at a specific
time point was determined by the Student 𝑡 test. A 𝑃 value
< 0.05 was considered significant.
3. Results
3.1. Hemodynamic Parameters. All the animals in both
groups survived through the experiment. Table 1 displays the
hemodynamic and physiological parameters recorded before
and after ECC. No differences between the two groups were
demonstrated.
3.2. Inflammatory Signalling Pathways Activation on Leuko-
cytes. The kinetics of leukocyte activation were determined
by measuring p38 phosphorylation and NF-𝜅B phosphoryla-
tion in leukocytes. Intracellular staining and flow-cytometry
demonstrated that ECC induced phosphorylation of both
p38 (Figure 1(a)) and NF-𝜅B (Figure 1(b)) in mononuclear
cells and granulocytes after ECC. Moreover the amount
of leukocyte activation was significantly higher in ECC +
oxygenator group.
Figure 2 shows representative flow-cytometry analysis
before ECC and after ECC in each group. A significant
depletion of mononuclear cells and granulocytes after ECC +
oxygenator is evident.
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Figure 1: P38 and NF-𝜅B activation in leukocytes in response to ECC was significantly higher in presence of oxygenator. Peripheral blood
samples were collected at baseline, before and after ECC. Leukocytes were fixed and permeabilized before intracellular staining using Alexa
Fluor 568-conjugated antibodies that recognize (a)Thr180/Tyr182 phosphorylated p38 or (b) Ser529 phosphorylated NF-𝜅B or with isotype-
matched antibodies as a control. After lysis of red blood cells, fluorescence of granulocytes or mononuclear cells was quantified by flow-
cytometry (after gating of cells by size and granularity). Mean fluorescence levels were calculated after subtracting values from isotype-control
antibodies. Mean values are shown with standard deviations. ∗
𝑃
< 0.05 between the two groups at the same time point.
3.3. Inflammatory Response and Organ Injury. Plasma
levels of TNF-𝛼 (Figure 3(a)), neutrophil elastase (NE)
(Figure 3(b)), and IL-6 (Figure 3(c)) increased after ECC in
both groups. However they were significantly higher in ECC
+ oxygenator compared to ECC − oxygenator (𝑃 < 0.01).
Rats receiving ECC + oxygenator demonstrated a recog-
nized feature of pulmonary injury, characterized by edema,
hemorrhage, increased thickness of alveolar wall, and inflam-
matory cells into alveolar spaces (Figure 4(a)). The lung
injury scores were therefore significantly higher in ECC +
oxygenator (4.50 ± 0.50) than in ECC − oxygenator (3.0 ±
1.0; 𝑃 < 0.001) (Figure 4(b)).
4. Discussion
The present study has generated fundamental information
on the role of oxygenator of ECC in activating inflammatory
signalling pathways on leukocytes. By the use of a previously
reported and validated rat model of ECC [11, 12], we have
demonstrated for the first time that oxygenator has a piv-
otal role in triggering leukocyte activation and subsequent
inflammatory response.
Given the recognized role of p38 and NF-𝜅B in the
transcriptional induction of proinflammatorymolecules [14–
16], we have demonstrated that ECC + oxygenator leads to a
significant phosphorylation (i.e., activation) of both p38 and
4 Mediators of Inflammation
0
0
SS
C-
A
FSC-A
250k
250k
200 k
200 k
150k
150k
100 k
100 k
50k
50k
(a)
0
0
SS
C-
A
FSC-A
250k
250k
200 k
200 k
150k
150k
100 k
100 k
50k
50k
(b)
0
0
SS
C-
A
FSC-A
250k
250k
200 k
200 k
150k
150k
100 k
100 k
50k
50k
(c)
Figure 2: Representative flow-cytometry analysis at baseline (a), after ECC without oxygenator (b) and after ECC with oxygenator (c). A
significant depletion of mononuclear cells and granulocytes after ECC + oxygenator is evident.
NF-𝜅B in leukocytes.Theunderlyingmechanismmay involve
contact-activation of blood components [17, 18]. Therefore it
is possible to argue that the contact-activation between blood
components and ECC surfaces is mainly produced in the
oxygenator. The latter is indeed an essential component of
ECC circuits in clinical setting [19]. Both CPB and ECMO are
based on the performance of oxygenator to support circula-
tory and respiratory functions during cardiac surgery opera-
tions or critical cardiorespiratory diseases, respectively [20].
Surface coating of ECC circuits, oxygenator included,
with heparin or phosphorylcholine has been proved to reduce
the inflammatory response [21–24]. This is detectable not
only on the basis of laboratory results but also by clinical
parameters like reduced respiratory index and improved pul-
monary and coagulation function in pediatric patients [21–
23]. Therefore coated ECC equipment has become a clinical
standard since beginning of 2000. However surface coating
with either heparin or phosphorylcholine has not resolved the
clinical problem of inflammatory response induced by ECC
[24].
Many rat models of ECC have been proposed recently
in order to assess molecular mechanisms responsible for
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Figure 3: Systemic inflammatory response assessed by TNF-𝛼 (a), neutrophil elastase (NE) (b), and IL-6 (c) levels in plasma. ∗
𝑃
< 0.01
versus the other group at the same time point.
Table 1: Hemodynamic and physiological parameters.
Before ECC After ECC
− oxygenator + oxygenator − oxygenator + oxygenator
Heart rate (bpm) 287 ± 5 292 ± 8 314 ± 11 304 ± 10
MAP (mmHg) 58.3 ± 9.0 60.3 ± 8.3 50.5 ± 8.0 55.1 ± 9.7
Haematocrit (%) 34.5 ± 1.1 33.5 ± 1.8 11.2 ± 6.1 10.2 ± 5.8
Haemoglobin (g/dL) 12.8 ± 0.6 13.0 ± 0.9 4.8 ± 1.2 5.2 ± 0.9
WBC (×103/mm3) 6.2 ± 1.8 5.5 ± 0.7 3.1 ± 0.4 2.7 ± 0.5
SaO2 (%) 98.2 ± 0.5 97.9 ± 0.4 95.2 ± 0.6 96.0 ± 1.1
PaO2 (mmHg) 72.3 ± 5.8 75.0 ± 4.1 69.0 ± 3.0 70.2 ± 9.0
PaCO2 (mmHg) 40.3 ± 5.9 43.0 ± 7.0 39.9 ± 4.0 42.3 ± 6.5
pH 7.32 ± 0.05 7.38 ± 0.04 7.22 ± 0.12 7.14 ± 0.20
BE (mmol/L) −4.3 ± 1.2 −3.1 ± 1.5 −10.1 ± 4.7 −11.7 ± 6.2
HCO3 (mmol/L) 24.1 ± 7.8 22.0 ± 6.1 11.0 ± 10.1 16.1 ± 9.8
WBC=white blood cells; bpm = beats per minute; MAP =mean arterial pressure; SaO2 = arterial oxygen saturation; PaO2 = partial pressure of arterial oxygen;
PaCO2 = partial pressure of arterial carbon dioxide; BE = base excess; HCO3 = standard bicarbonate. Data represent means ± SE.
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Figure 4: Lung injury. Representative histological images (magnification 40x) of right lung fixed in formaldehyde, sectioned, and stained
with haematoxylin and eosin (a). The acute lung injury score was calculated (b). ∗
𝑃
< 0.01.
activation of inflammatory response during ECC and to
study possible therapeutic interventions [4–10]. All of these
models are based on different home-made oxygenators. We
have previously proposed a validated model of ECC in rat
with a miniaturized hollow fiber oxygenator with clinical
characteristics and manufactured with industrial standards
by one of the leading producers of clinical oxygenators
[11]. The present work demonstrated that a clinical relevant
oxygenator has a major impact on leukocyte activation
and systemic inflammatory response with implications in
organ dysfunction. Therefore experimental studies aimed
at investigating inflammatory response during ECC should
be based on models with a standardized, reproducible, and
clinical relevant oxygenator.
5. Conclusions
Oxygenator has a major role in leukocyte activation, inflam-
matory response, and organ dysfunction during ECC.
The present results suggest that experimental animal
models of ECC used in translational research on inflamma-
tory response should be based on standardized, reproducible
oxygenators with clinical characteristics.
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